EVEN IS WITHIN REACH
SkinMedica® introduces the next generation of skin brightening: pigment correction. Addressing multiple origins of visible discoloration, NEW SkinMedica® Lytera® 2.0 Pigment Correcting Serum takes a comprehensive approach to visibly correct the appearance of uneven pigmentation and help prevent future discoloration.
Lytera® 2.0 Pigment Correcting Serum addresses even the most stubborn hyperpigmentation, demonstrating clinical efficacy for a variety of skin types and ethnicities with continued improvement over time.
Hyperpigmentation is the clinical name for any uneven darkening of the skin. This is caused by an excess production of melanin, a pigment that gives skin its color. Some skin discoloration may be temporary but if it persists over time, that may indicate a more chronic skin condition.
A number of different factors cause hyperpigmentation, including the environment, solar radiation, hormonal changes and pregnancy, which all can lead to an over production of pigment, or melanin, causing skin to look blotchy, spotted, and uneven.
Skin discoloration can have a deeper effect than what’s on the surface. Without a professional diagnosis, many feel at a loss to accurately identify their condition or even how to describe it. Some common terms include dark spots, blotches, or age spots.
Lytera® 2.0 does not contain any known teratogenic ingredients, ingredients known to harm mother and/or baby. Therefore, pregnancy is not considered a contraindication for Lytera® 2.0.
UNIQUE FORMULATION. REMARKABLE RESULTS
Lytera® 2.0, the new Skin Brightening System from SkinMedica improves upon its original formulation to include all skin types, and is safe for use in pregnancy. Harnessing a breakthrough ingredient blend and advanced pigment correcting technology, Lytera® 2.0 starts at the origin to support melanin balance that is disrupted by intrinsic and extrinsic factors, such as ethnic background, genetic makeup, hormones, UV radiation, inflammation and aging. The innovative formula is retinol and hydroquinone free, and works to support the skin’s ability to resist triggers that can cause reoccurring and future discoloration.
This formulation uses a combination of tranexamic acid, which brightens skin and evens skin tone, phenylethyl resorcinol, which is a compound that suppresses the expression of melanin in the skin, treating hyperpigmentation at the root. Niacinamide and Tetrapeptide-30 prevent new spots from forming, and aid in reduction of visible spots/hyperpigmentation, and the addition of a patented marine extract blend also corrects and prevents, as well as improving the moisture barrier in the skin. This newest formulation treats hyperpigmentation from the inside out, and 100% of patients in clinical trials reported improvement of skin tone.